Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CLYM
CLYM logo

CLYM News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CLYM News

Climb Biopress Reports Q4 Earnings and Financial Position

4d agoseekingalpha

Wall Street Analysts Adjust Ratings

Feb 13 2026Benzinga

Top High Flyer Healthcare Stocks Revealed

Feb 02 2026seekingalpha

GE Vernova Expected to Surge by 33%? Check Out 10 Leading Analyst Predictions for Thursday

Dec 18 2025Benzinga

Promising Data on the Horizon: Can 2026 Results Propel Climb Bio Forward?

Dec 15 2025NASDAQ.COM

Climb Bio Appoints Adam Villa as Senior Vice President of Technical Operations and Ashley Jones as Senior Vice President of People and Workforce Strategy

Oct 21 2025Newsfilter

Climb Bio's Lead Drug Candidate Offers Significant Long-Term Potential for Small-Cap Biotech

Oct 16 2025Benzinga

Celestica Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations

Oct 16 2025Benzinga

CLYM Events

No data

No data

CLYM Monitor News

Climb Bio Inc reaches 52-week high amid promising drug developments

Dec 15 2025

CLYM Earnings Analysis

No Data

No Data

People Also Watch